Metraipolis › archive › dc_db35da5cb1b7

Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndrome — Europe PMC PMID:42376186

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42376186
DOI
10.1002/cti2.70113
License (as archived)
solo-consultazione
Archived
2026-10-07T22:23:19.560Z
SHA-256 of the archived text
5ac234204969cd39ea71f88ccca4eed8e96e138df139fb9d7f1e6a04b008d8d8
Stable URL of this page
https://metraipolis.com/documento/dc_db35da5cb1b7

How to cite

Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndrome — Europe PMC PMID:42376186 — Europe PMC (en), https://europepmc.org/article/MED/42376186 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db35da5cb1b7 (Metraipolis archive dc_db35da5cb1b7, sha256 5ac234204969cd39ea71f88ccca4eed8e96e138df139fb9d7f1e6a04b008d8d8)
BibTeX
@misc{dcdb35da5cb1b7,
  title = {Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndrome — Europe PMC PMID:42376186},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42376186},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db35da5cb1b7; sha256 5ac234204969cd39ea71f88ccca4eed8e96e138df139fb9d7f1e6a04b008d8d8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42376186. Agents can read the archived copy with the MCP tool read_document.